Proteome Sciences (LON:PRM) Trading Up 0.6% – Should You Buy?

Proteome Sciences plc (LON:PRM) shares were up 0.6% during mid-day trading on Monday . The company traded as high as GBX 2.30 and last traded at GBX 1.41. Approximately 248,823 shares traded hands during trading, a decline of 46% from the average daily volume of 464,412 shares. The stock had previously closed at GBX 1.40.

Proteome Sciences Price Performance

The company has a current ratio of 0.13, a quick ratio of 0.37 and a debt-to-equity ratio of -165.46. The company has a 50-day simple moving average of GBX 1.55 and a 200 day simple moving average of GBX 1.93. The company has a market cap of £4.95 million, a P/E ratio of -1.36 and a beta of 0.07.

Proteome Sciences (LON:PRM) last released its earnings results on Wednesday, April 15th. The company reported GBX (1.04) earnings per share for the quarter. The business had revenue of GBX 376 million for the quarter. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.